Shown verbatim: the complete text as captured from the official PDF posted by the Tennessee General Assembly, fetched 2026-09-25. Page and line markers are part of the official record; nothing is edited or removed. This is the chaptered version. The official bill page.
•••••o
'i;;;. .
. .-~ ......~...... ,
0 ·~
~~ ~
:(~f(AGRIClJi :,,..;i :
~ ! ~\. - ---'~ }2 J
c,--:.-".. ~' ,
t~ ~ ,;."··•·..••••..•;~
·····••"
Staie efJeltflMse.e
PUBLIC CHAPTER NO. 302
SENATE BILL NO. 48
By Haile
Substituted for: House Bill No. 491
By Farmer, Powers
AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
SECTION 1. Tennessee Code Annotated, Section 20-13-203, is amended by deleting the
section and substituting instead the following:
Upon written approval of the governor and comptroller of the treasury, the attorney
general and reporter has the authority to release any pending or future claim of governmental
entities against McKesson Corporation, Cardinal Health, Inc., AmerisourceBergen
Corporation, Johnson & Johnson, Allergan Finance, LLC, CVS Health Corporation, Teva
Pharmaceutical Industries Ltd., Walgreen Co., Walmart Inc., K-VA-T Food Stores, Inc., The
Kroger Co., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., lndivior Inc., Sun
Pharmaceutical Industries, Inc., Viatris Inc., and Purdue Pharma LP. and affiliates,
subsidiaries, and other entities related to these companies that are released in the McKesson
Corporation, Cardinal Health, Inc., AmerisourceBergen Corporation, Johnson & Johnson,
Allergan Finance, LLC, CVS Health Corporation, Teva Pharmaceutical Industries Ltd.,
Walgreen Co., Walmart Inc.,- K-VA-T Food Stores, Inc., The Kroger Co., Amneal
Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., lndivior Inc., Sun Pharmaceutical
Industries, Inc., Viatris Inc., and Purdue Pharma LP. settlement agreements or bankruptcy
plans and related agreements for activities related to the manufacture, marketing, distribution,
dispensing, or sale of opioids, or related activities, if the attorney general and reporter deems
the release necessary to the interest of the state in the resolution of the opioid crisis.
SECTION 2. Tennessee Code Annotated, Section 33-11-103(p), is amended by deleting
subsection (p) and substituting instead the following:
(p) For proceeds received from a statewide opioid settlement agreement or bankruptcy
plan and related agreements with McKesson Corporation, Cardinal Health, Inc.,
AmerisourceBergen Corporation, Johnson & Johnson, Allergan Finance, LLC, CVS Health
Corporation, Teva Pharmaceutical Industries Ltd., Walgreen Co., Walmart Inc., K-VA-T Food
Stores, Inc., The Kroger Co., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc.,
lndivior Inc., Sun Pharmaceutical Industries, Inc., Viatris Inc., or Purdue Pharma LP. or
affiliates, subsidiaries, or other related entities that are deposited in the opioid abatement fund,
the council shall disburse thirty-five percent (35%) of these proceeds to counties that join the
settlement. The council shall disburse these proc~eds to counties subject of subsections (q)-
(s). The council shall disburse the remaining sixty-five percent (65%) of such proceeds for
stat~wide, regional, or local opioid abatement and remediation purposes pursuant to § 33-11-
105.
SECTION 3. If any provision of this act or its application to any person or circumstance is held
invalid, the invalidity does not affect other provisions or applications of the act that can be given effect
without the invalid provision or application, and to that end, the provisions of this act are severable.
SECTION 4. This act takes effect upon becoming a law, the public welfare requiring it.
SENATE BILL NO. 48
PASSED: April 16, 2025
RANDY l\cNALLY
SPEAKER OF THE'sENA TE
<:::: -
CAMEROP5ilii'TON, SPEAKER
HOUSE OF REPRESENTATIVES
~ APPROVED t h i s ~ day of 2025
~VA..,
BILL LEE, GOVERNOREvery fact on this page links to its source, starting with the official bill record.